Major Depressive Disorder Clinical Trials in Wichita Falls, Texas

4 studies are recruiting for major depressive disorder in Wichita Falls, Texas right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder

    The goal of this clinical trial is to learn if zelquistinel works to treat depression in adults. It will also learn about the safety of zelquistinel. The main questions it aims to answer are: Does zelquistinel reduce depression scores in participants compared to participants who take a placebo (a l…

    Stage
    Phase 2
    Ages
    18 to 64
    Site
    Grayline Research Center, Wichita Falls, Texas
    Locations
    34 in total
    Run by
    Syndeio Biosciences, Inc

    See if you can join NCT06547489 on ClinicalTrials.gov

  2. A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder

    X-NOVA2 is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the clinical efficacy, safety, and tolerability of azetukalner as a monotherapy in adult participants diagnosed with Major Depressive Disorder (MDD)

    Stage
    Phase 3
    Ages
    18 to 74
    Site
    Grayline Research Center, Wichita Falls, Texas
    Locations
    51 in total
    Run by
    Xenon Pharmaceuticals Inc.

    See if you can join NCT06775379 on ClinicalTrials.gov

  3. A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

    The primary objective of this study is to evaluate the efficacy of NBI-1065845 compared with placebo as an adjunctive treatment in delaying relapse of depressive symptoms (maintenance of effect) in participants with MDD.

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Neurocrine Clinical Site, Wichita Falls, Texas
    Locations
    60 in total
    Run by
    Neurocrine Biosciences

    See if you can join NCT07196501 on ClinicalTrials.gov

  4. A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms

    This is a randomized, double-blind, active-controlled, multi-center study to evaluate the efficacy of AXS-05, compared to bupropion, in preventing the relapse of depressive symptoms in subjects with major depressive disorder (MDD) who have responded to treatment with AXS-05.

    Stage
    Phase 4
    Ages
    18 to 65
    Site
    Clinical Research Site, Wichita Falls, Texas
    Locations
    40 in total
    Run by
    Axsome Therapeutics, Inc.

    See if you can join NCT06223880 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.